This site is a comprehensive resource for biotech enthusiasts, including investors, researchers, media, etc. You'll find information about drug discovery and development, the FDA approval process, and loads of links and information about specific drugs and biotech companies.
BiotechDueDiligence's Latest Posts
Part 2 of this week's double dose of biotech / pharma Twitter highlights here at BiotechDueDiligence. Thanks for checking out this new feature, and we welcome any feedback! Major credit as always due to @23aloha. Featured tickers: $ABBV $AGIO $ALNY $AMRN $ARWR $CEMP $CRDC $ESPR $FMI $GILD $ISRG $NSPH $PPHM $PSDV $SHPG $SNSS @ashishkjha Amazing thing about 'missteps in medicine' is that it tends to cluster and cascade. Just like excellence.— Amitabh Chandra (@amitabhchandra2) […]
A little late, but what a week it was! Enjoy this round-up of biotech-related tweets that captured the moment. Thanks as always to @23aloha for the lion's share of the curation duties. Featured tickers: $ARWR $BLUE $BMY $DRTX $GILD $KITE $PFE $SNSS $SRPT $ZIOP $IBB $XBI What's missing from brouhaha over drug pricing? Congress chose NOT to give the CMS negotiating power on prices. $PFE Kindler's last hurrah— Sally Church (@MaverickNY) October 6, 2014 Happy for […]
Artificial sweeteners induce glucose intolerance by altering the gut microbiotaSuez et al. Nature.Patient-Contributed Tumor Genetics Data: A Pathway to Better Drug DevelopmentBenita et al. AJMC.Reversion of advanced Ebola virus disease in nonhuman primates with ZMappQiu et al. Nature.Ice bucket challenge cash may help derisk ALS drug researchManasi Vaidya. Nature Medicine.Development of the clinical next-generation sequencing industry in a shifting policy climateCurnutte et al. Nature […]
FDA Issues Draft LDT Guidance Documents; Provides 120-Day Comment Period and will Host October Public MeetingWolszon et al. (FDA Law Blog) $FMIHedge Funds Listen In on Patient Chats for Pharma BetsCaroline Chen (Bloomberg)'60 Minutes' Just Attacked High Drug Prices. Here's What You Should KnowMatthew Herper (Forbes)‘Financial Toxicity:’ Who’s Really to Blame for High Cancer Drug Prices?Ed Silverman (Pharmalot / WSJ)Setting the Record Straight on GRAS: Part 2Carvajal and McColl […]
Enjoy the latest round-up of the top tweets of the week that drove and captured the conversation this week. Thanks as always to @23aloha for the heavy lifting on the curation. Featured tickers: $AKBA $ANTH $BMY $NWBO $RHHBY $RTRX $SLXP $TKMR $TNXP Even with the placebo group crossing over to pertuzumab, the OS w/ combo is still fantastic #CLEOPATRA #esmo14 pic.twitter.com/rCoPwyf82B— Sally Church (@MaverickNY) September 28, 2014 @Jerry_DurhamPT absolutely, health first, […]
Log in to leave a comment